NCT04177680View on ClinicalTrials.gov

Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

November 27, 2020

Study Completion Date

January 18, 2021

Conditions
Hypertriglyceridemia
Interventions
DRUG

Omega 3 pentaenoic acid

Encapsulated omega-3 pentaenoic acid

DRUG

icosapent ethyl

Encapsulated omega-3 acid ethyl esters

Trial Locations (8)

23294

Matinas Investigational site, Richmond

32216

Matinas Investigational Site, Jacksonville

33458

Matinas Investigational site, Jupiter

34952

Matinas Investigational Site, Port Saint Lucie

40213

Matinas Investigational site, Louisville

46260

Matinas Investigational site, Indianapolis

60101

Matinas Investigational Site, Addison

60640

Matinas Investigational Site, Chicago

Sponsors
All Listed Sponsors
collaborator

Matinas Biopharma, Inc

INDUSTRY

collaborator

MB Clinical Research and Consulting LLC

UNKNOWN

lead

Matinas BioPharma Nanotechnologies, Inc.

INDUSTRY